An initial report of a new biological marker for bipolar disorder: P85 evoked brain potential

Bipolar Disorders

Volumn 11, Issue 6, 2009, Pages 596-609

  Patterson, Julie V ^a,b   Sandman, Curt A ^a   Ring, Alex ^a   Jin, Yi ^a   Bunney Jr , William E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biological marker; Bipolar disorder; Evoked potentials; Schizophrenia

Indexed keywords

ADULT; ARTICLE; BIPOLAR I DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; ELECTROENCEPHALOGRAPHY; EVOKED AUDITORY RESPONSE; FEMALE; HUMAN; MALE; P50 EVOKED AUDITORY RESPONSE; P85 EVOKED AUDITORY RESPONSE; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; STRUCTURED INTERVIEW; WAVEFORM;

ACOUSTIC STIMULATION; ADULT; ANTIMANIC AGENTS; BIOLOGICAL MARKERS; BIPOLAR DISORDER; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; LITHIUM COMPOUNDS; MALE; NEURAL INHIBITION; PSYCHOTIC DISORDERS; REACTION TIME; ROC CURVE; SCHIZOPHRENIA, PARANOID; SENSORY GATING; STATISTICS AS TOPIC; VALPROIC ACID; YOUNG ADULT;

EID: 68749112744     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2009.00734.x     Document Type: Article

References (72)

1. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 617-627.
2. Akiskal HS, Bourgeois ML, Angst J, Post R, Moller H, Hirschfeld R. Re-evaluating the prevalence of and diagnostic composition within the broad clinical spectrum of bipolar disorders. J Affect Disord 2000; 59 (Suppl. 1): S5-S30.
3. Hirschfeld RM, Calabrese JR, Weissman MM et al. Screening for bipolar disorder in the community. J Clin Psychiatry 2003; 64: 53-59.
4. Judd LL, Akiskal HS. The prevalence and disability of bipolar spectrum disorders in the US population: Re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord 2003; 73: 123-131.
5. Post RM, Denicoff KD, Leverich GS et al. Morbidity in 258 bipolar outpatients followed for 1year with daily prospective ratings on the NIMH Life Chart Method. J Clin Psychiatry 2003; 64: 680-690.
6. Harrow M, MacDonald AW, Sands JR, Silverstein ML. Vulnerability to delusions over time in schizophrenia and affective disorders. Schizophr Bull 1995; 21: 95-109.
7. Valtonen H, Suominen K, Mantere O, Leppamaki S, Arvilommi P, Isometsa ET. Suicidal ideation and attempts in bipolar I and II disorders. J Clin Psychiatry 2005; 66: 1456-1462.
8. Einat H. Different behaviors and different strains: Potential new ways to model bipolar disorder. Neurosci Biobehav Rev 2007; 31: 850-857.
9. Thaker GK. Neurophysiological endophenotypes across bipolar and schizophrenia psychosis. Schizophr Bull 2008; 34: 760-773.
10. Braff DL, Freedman R, Schork NJ, Gottesman II. Deconstructing schizophrenia: An overview of the use of endophenotypes in order to understand a complex disorder. Schizophr Bull 2007; 33: 21-32.
11. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160: 636-645.
12. Freedman R, Adler LE, Gerhardt GA et al. Neurobiological studies of sensory gating in schizophrenia. Schizophr Bull 1987; 13: 669-678.
13. Freedman R, Ross R, Leonard S et al. Early biomarkers of psychosis. Dialogues Clin Neurosci 2005; 7: 17-29.
14. Patterson JV, Hetrick WP, Boutros NN et al. P50 sensory gating ratios in schizophrenics and controls: A review and data analysis. Psychiatry Res 2008; 158: 226-247.
15. Clementz BA, Geyer MA, Braff DL. Poor P50 suppression among schizophrenia patients and their first-degree biological relatives. Am J Psychiatry 1998; 155: 1691-1694.
16. Waldo MC, Adler LE, Leonard S et al. Familial transmission of risk factors in the first-degree relatives of schizophrenic people. Biol Psychiatry 2000; 47: 231-239.
17. Shifman S, Bronstein M, Sternfeld M et al. COMT: A common susceptibility gene in bipolar disorder and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2004; 128: 61-64.
18. Maier W, Zobel A, Wagner M. Schizophrenia and Bipolar disorder: differences and overlaps. Curr Opin Psychiatry 2006; 19: 165-170.
19. Blumberg HP, Kaufman J, Martin A et al. Amygdala and hippocampal volumes in adolescents and adults with bipolar disorder. Arch Gen Psychiatry 2003; 60: 1201-1208.
20. Knable MB. Schizophrenia and bipolar disorder: Findings from studies of the Stanley Foundation Brain Collection. Schizophr Res 1999; 39: 149-152.
21. Clark L, Iversen SD, Goodwin GM. A neuropsychological investigation of prefrontal cortex involvement in acute mania. Am J Psychiatry 2001; 158: 1605-1611.
22. Knight RT, Staines WR, Swick D, Chao LL. Prefrontal cortex regulates inhibition and excitation in distributed neural networks. Acta Psychol 1999; 101: 159-178.
23. Freedman R, Coon H, Myles-Worsley M et al. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci U S A 1997; 94: 587-592.
24. Flomen RH, Collier DA, Osborne S et al. Association study of CHRFAM7A copy number and 2bp deletion polymorphisms with schizophrenia and bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet 2006; 141: 571-575.
25. Altshuler LL, Bartzokis G, Grieder T et al. An MRI study of temporal structures in men with bipolar disorder or schizophrenia. Biol Psychiatry 2000; 48: 147-162.
26. Hirayasu Y, Shenton ME, Salisbury DF et al. Lower left temporal lobe MRI volumes in patients with first-episode schizophrenia compared with psychotic patients with first-episode affective disorder and normal subjects. Am J Psychiatry 1998; 155: 1384-1391.
27. Velakoulis D, Pantelis C, McGorry PD et al. Hippocampal volume in first-episode psychoses and chronic schizophrenia. Arch Gen Psychiatry 1999; 56: 133-140.
28. Swayze VW, Andreason NC, Alliger RJ, Yuh WTC, Ehrhardt JC. Subcortical and temporal structures in affective disorder and schizophrenia: A magnetic resonance imaging study. Biol Psychiatry 1992; 31: 221-240.
29. Adler LE, Gerhardt GA, Franks R et al. Sensory physiology and catecholamines in schizophrenia and mania. Psychiatry Res 1990; 31: 297-309.
30. Baker NJ, Staunton M, Adler LE et al. Sensory gating deficits in psychiatric inpatients: Relation to catecholamine metabolites in different diagnostic groups. Biol Psychiatry 1990; 27: 519-528.
31. Franks RD, Adler LE, Waldo MC, Alpert J, Freedman R. Neurophysiological studies of sensory gating in mania: Comparison with schizophrenia. Biol Psychiatry 1983; 18: 989-1005.
32. Olincy A, Martin L. Diminished suppression of the P50 auditory evoked potential in bipolar disorder subjects with a history of psychosis. Am J Psychiatry 2005; 162: 43-49.
33. Sánchez-Morla EM, García-Jiménez MA, Barabash A et al. P50 sensory gating deficit is a common marker of vulnerability to bipolar disorder and schizophrenia. Acta Psychiatr Scand 2008; 117: 313-318.
34. Schulze KK, Hall M, McDonald C et al. P50 auditory evoked potential suppression in bipolar disorder patients with psychotic features and their unaffected relatives. Biol Psychiatry 2007; 62: 121-128.
35. Hall M, Schulze K, Sham P et al. Further evidence for shared genetic effects between psychotic bipolar disorder and P50 suppression. Am J Med Genet 2008; 147B: 619-627.
36. Martin L, Hall MH, Ross R, Zerbe G, Freedman R, Olincy A. Physiology of schizophrenia, bipolar disorder, and schizoaffective disorder. Am J Psychiatry 2007; 164: 1900-1906.
37. Boutros N, Zouridakis G, Rustin T, Peabody C, Warner D. The P50 component of the auditory evoked potential and subtypes of schizophrenia. Psychiatry Res 1993; 47: 243-254.
38. Kisley MA, Olincy A, Freedman R. The effect of state on sensory gating: comparison of waking, REM and non-REM sleep. Clin Neurophysiol 2001; 112: 1154-1165.
39. Woods DL, Alain C. Conjoining three auditory features: An event-related brain potential study. J Cogn Neurosci 2001; 13: 492-509.
40. Näätanen R, Picton T. The N1 wave of the human electric and magnetic response to sound: A review and an analysis of the component structure. Psychophysiology 1987; 24: 375-425.
41. Wood CC, Wolpaw JR. Scalp distribution of human auditory evoked potentials. II. Evidence for overlapping sources and involvement of auditory cortex. Electroencephalogr Clin Neurophysiol 1982; 54: 25-38.
42. Woods DL. The component structure of the N1 wave of the human auditory evoked potential. In: Karmos G, Molnar M, Csepe V, Czigler I, Desmedt JE eds. Perspectives of Event-related Potentials Research (Electroencephalography and Clinical Neurophysiology Suppl. 44). Amsterdam: Elsevier Science BV, 1995: 102-109.
43. Shostak VI, Lytaev SA, Golubeva LV. Topography of afferent and efferent flows in the mechanisms of auditory selective attention. Neurosci Behav Physiol 1995; 25: 378-385.
44. Katz J, Burkard R, Medwetsky L (Eds). Handbook of Clinical Audiology. Baltimore: Lippincott Williams & Wilkins, 2001.
45. Patterson JV, Jin Y, Gierczak M et al. Effects of temporal variability on P50 and the gating ratio in schizophrenia. Arch Gen Psychiatry 2000; 57: 57-64.
46. Clementz BA, Blumenfeld LD. Multichannel electroencephalographic assessment of auditory evoked response suppression in schizophrenia. Exp Brain Res 2001; 139: 377-390.
47. Kanno A, Nakasato N, Murayama N, Yoshimoto T. Middle and long latency peak sources in auditory evoked magnetic fields for tone bursts in humans. Neurosci Lett 2000; 293: 187-190.
48. Yvert B, Crouzeix A, Bertrand O, Seither-Preisler A, Pantev C. Multiple supratemporal sources of magnetic and electric auditory evoked middle latency components in humans. Cereb Cortex 2001; 11: 411-423.
49. Crawford HJ, McClain-Furmanski D, Castagnoli N, Castagnoli K. Enhancement of auditory sensory gating and stimulus-bound gamma band (40Hz) oscillations in heavy tobacco smokers. Neurosci Lett 2002; 317: 151-155.
50. Boutros NN, Belger A, Campbell D, D'Souza C, Krystal J. Comparison of four components of sensory gating in schizophrenia and normal subjects: a preliminary report. Psychiatry Res 1999; 88: 119-130.
51. Boutros N, Korzyukov O, Jansen B, Fiengold A, Bell M. Sensory gating deficits during the mid-latency phase of information processing in medicated schizophrenia patients. Psychiatry Res 2004; 126: 203-215.
52. Boutros NN, Zouridakis G, Overall J. Replication and extension of P50 findings in schizophrenia. Clin Electroencephalogr 1991; 22: 40-45.
53. Adler LE, Hoffer LD, Wiser A, Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patterns. Am J Psychiatry 1993; 150: 1856-1861.
54. Erwin RJ, Shtasel D, Gur RE. Effects of medication history on midlatency auditory evoked responses in schizophrenia. Schizophr Res 1994; 11: 251-258.
55. Nagamoto HT, Adler LE, Hea RA, Griffith JM, McRae KA, Freedman R. Gating of auditory P50 in schizophrenics: Unique effects of clozapine. Biol Psychiatry 1996; 40: 181-188.
56. Nagamoto HT, Adler LE, Waldo MC, Griffith J, Freedman R. Gating of auditory response in schizophrenics and normal controls. Effects of recording site and stimulation interval on the P50 wave. Schizophr Res 1991; 4: 31-40.
57. Ringel TM, Heidrich A, Jacob CP, Pfuhlmann B, Stoeber G, Fallgatter AJ. Sensory gating deficit in a subtype of chronic schizophrenic patients. Psychiatry Res 2004; 125: 237-245.
58. Basar E, Rosen B, Basar-Eroglu C, Greitschus F. The association between 40-Hz EEG and middle latency response of the auditory evoked potential. Int J Neurosci 1987; 33: 103-117.
59. Clementz BA, Blumenfeld LD, Cobb S. The gamma band response may account for poor P50 suppression in schizophrenia. Neuroreport 1997; 8: 3889-3893.
60. Muller MM, Keil A, Kissler J, Gruber T. Suppression of the auditory middle-latency response and evoked gamma-band response in a paired-click paradigm. Exp Brain Res 2001; 136: 474-479.
61. Paternoster R, Brame R, Mazarolle P, Piquero A. Using correct statistical test for equality of regression coefficients. Criminol 1998; 36: 859-866.
62. Adler CM, DelBello MP, Jarvis K, Levine A, Adams J, Strakowski SM. Voxel-based study of structural changes in first-episode patients with bipolar disorder. Biol Psychiatry 2007; 61: 776-781.
63. Dickstein DP, Milham MP, Nugent AC et al. Frontotemporal alterations in pediatric bipolar disorder. Results of a voxel based study. Arch Gen Psychiatry 2005; 62: 734-741.
64. Buffalo EA, Bellgowan PS, Martin A. Distinct roles for medial temporal lobe structures in memory for objects and their locations. Learn Mem 2006; 13: 638-643.
65. Preston AR, Gabrieli JD. Different functions for different medial temporal lobe structures? Learn Mem 2002; 9: 215-217.
66. Clark K, Goodwin GM. State- and trait-related deficits in sustained attention in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 2004; 254: 61-68.
67. Burdick KE, Goldberg JF, Harrow M, Faull RN, Malhotra AK. Neurocognition as a stable endophenotype in bipolar disorder and schizophrenia. J Nerv Ment Dis 2006; 194: 255-260.
68. Liu SK, Chiu C-H, Chang C-J, Hwang T-J, Hwu H-G, Chen WJ. Deficits in sustained attention in schizophrenia and affective disorders: Stable versus state-dependent markers. Am J Psychiatry 2002; 159: 975-982.
69. Robinson LJ, Ferrier IN. Evolution of cognitive impairment in bipolar disorder: A systematic review of cross-sectional evidence. Bipolar Disord 2006; 8: 103-116.
70. Martínez-Arán A, Vieta E, Reinares M et al. Cognitive function across manic or hypomanic, depressed, and euthymic states in bipolar disorder. Am J Psychiatry 2004; 161: 262-270.
71. Correll CU, Penzner JB, Lencz T et al. Early identification and high-risk strategies for bipolar disorder. Bipolar Disord 2007; 9: 324-338.
72. Lenox RH, Gould TD, Manji HK. Endophenotypes in bipolar disorder. Am J Med Genet 2002; 114: 391-406.